Note: EPS may not be comparable

MedEquities Realty Trust (NYSE: MRT) reported Q4 EPS of $0.18, versus $0.00 reported last year.

Highlights – Fourth Quarter and Year to Date

• Reported results attributable to common stockholders for the fourth quarter of 2017 of net income of $0.18 per diluted share, Funds from Operations ("FFO") of $0.32 per diluted share and Adjusted FFO ("AFFO") of $0.31 per diluted share.
• Closed on the acquisition of one acute care surgical hospital, which previously served as collateral for a mortgage loan, and a commitment to fund construction of a residential treatment facility for an incremental investment of $11 million during the fourth quarter of 2017.
• Originated a construction mortgage note receivable with a total funding commitment of $19.0 million in January 2018 secured by a behavioral health facility under development and originated a $5.4 million mezzanine loan to fund the development of an inpatient rehabilitation hospital.
• Issued 2018 per share guidance attributable to common stockholders of net income of $0.63, FFO of $1.17 to $1.21 and AFFO of $1.18 to $1.22.
• Declared a regular cash dividend of $0.21 per share for the fourth quarter of 2017.

GUIDANCE:

MedEquities Realty Trust sees FY2018 EPS of $0.63, versus the consensus of $0.63.

For earnings history and earnings-related data on MedEquities Realty Trust (MRT) click here.